Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Greenville › NPI 1043218944
Hospital

Pitt County Memorial Hospital, INC

Pitt County Memorial Hospital, INC was paid $60.24M by Medicaid between Jan 2018 and Dec 2024, across 239 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.

33Billing provider infoPITT COUNTY MEMORIAL HOSPITAL, INC
GREENVILLE, NC 27834
33aNPI1043218944assigned 07/13/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$60.24M
24GClaims943,128
24DCodes billed239
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#6 of 92
Median peer was paid$11.47M
This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018133,313$7.41M
2019112,988$6.64M
2020100,127$6.22M
2021216,027$13.65M
2022154,002$11.19M
2023119,577$8.38M
2024incomplete107,094$6.75M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 25% 103,802 100,288 $15.06M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 48,556 46,324 $13.80M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 9.3% 66,206 57,381 $5.62M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 7.8% 25,488 24,484 $4.71M
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3.2% 71,427 63,177 $1.95M
0225U 2.6% 4,256 3,802 $1.54M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.3% 49,362 43,147 $1.41M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.2% 3,691 3,474 $1.33M
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) 1.8% 570 340 $1.10M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 13,105 12,775 $1.09M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.6% 40,881 36,092 $993K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 110,594 95,176 $956K
227 more codes
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.5% 962 $901K
71046 Radiologic examination, chest; 2 views 1.2% 8,485 $729K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 12,392 $661K
G0378 Hospital observation service, per hour <1% 3,105 $584K
80053 Comprehensive metabolic panel <1% 56,596 $554K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 11,772 $380K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,943 $370K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 11,088 $362K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 348 $301K
A0436 Rotary wing air mileage, per statute mile <1% 568 $261K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,788 $256K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,009 $233K
36455 <1% 671 $213K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,323 $208K
96375 Therapeutic injection; each additional sequential IV push <1% 3,086 $156K
86780 <1% 8,218 $153K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 219 $147K
86703 <1% 8,516 $139K
95782 <1% 163 $138K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,614 $137K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,014 $125K
84443 Thyroid stimulating hormone (TSH) <1% 5,255 $115K
87088 <1% 10,112 $112K
82728 <1% 5,162 $96K
81001 <1% 25,083 $94K
A0425 Ground mileage, per statute mile <1% 829 $94K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,547 $94K
A0427 Emergency ambulance ride, advanced life support <1% 287 $92K
J3490 Unclassified drugs <1% 5,538 $91K
80048 Basic metabolic panel (calcium, ionized) <1% 11,967 $91K
81025 <1% 10,898 $91K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 76 $90K
86850 <1% 5,292 $83K
99157 <1% 195 $82K
J9271 Injection, pembrolizumab, 1 mg <1% 65 $81K
36430 <1% 173 $63K
86922 <1% 427 $61K
85045 <1% 11,038 $61K
83020 <1% 3,176 $58K
86762 <1% 2,748 $55K
82570 <1% 6,778 $53K
76770 <1% 311 $50K
84439 <1% 3,956 $49K
87631 <1% 563 $48K
86787 <1% 2,613 $46K
62323 <1% 252 $46K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 517 $44K
87641 <1% 1,834 $44K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 630 $44K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 362 $43K
36415 Collection of venous blood by venipuncture <1% 18,237 $43K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 171 $43K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 612 $42K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 592 $39K
88142 <1% 1,373 $38K
80061 Lipid panel <1% 2,201 $37K
86923 <1% 326 $37K
36591 <1% 2,290 $36K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 41 $36K
86803 <1% 1,642 $35K
87340 <1% 2,805 $35K
80069 <1% 3,282 $35K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,171 $35K
81003 <1% 11,562 $33K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 707 $32K
84156 <1% 6,068 $30K
86902 <1% 986 $30K
83735 <1% 6,007 $30K
82962 <1% 7,901 $30K
J2469 Injection, palonosetron hcl, 25 mcg <1% 114 $30K
87081 <1% 3,659 $27K
84484 <1% 2,277 $26K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 84 $24K
86900 <1% 5,977 $24K
71250 <1% 134 $24K
86901 <1% 5,977 $24K
96361 Intravenous infusion, hydration; each additional hour <1% 317 $24K
83021 <1% 979 $23K
82784 <1% 727 $23K
83615 <1% 2,836 $23K
70450 Computed tomography, head or brain; without contrast material <1% 57 $22K
82951 <1% 1,118 $21K
83690 <1% 2,417 $21K
70551 Magnetic resonance imaging, brain; without contrast material <1% 24 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,473 $20K
96376 <1% 215 $18K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 80 $18K
85027 <1% 1,996 $18K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,762 $17K
87150 <1% 404 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 54 $17K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 147 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 1,084 $14K
J0475 Injection, baclofen, 10 mg <1% 40 $14K
82610 <1% 558 $12K
84466 <1% 666 $12K
86160 <1% 429 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,529 $11K
86141 <1% 651 $11K
83540 <1% 1,170 $11K
84100 <1% 4,099 $10K
78815 Positron emission tomography (PET) for limited area imaging <1% 27 $10K
74240 <1% 25 $10K
82607 <1% 432 $10K
86162 <1% 411 $10K
85660 <1% 983 $9K
87430 <1% 642 $9K
82950 <1% 1,455 $9K
99155 <1% 59 $8K
92567 <1% 337 $8K
83970 <1% 242 $8K
92588 <1% 54 $8K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 27 $7K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 746 $7K
84300 <1% 1,120 $7K
74018 <1% 65 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,191 $7K
93886 <1% 27 $6K
87077 <1% 571 $6K
84133 <1% 1,100 $6K
87070 <1% 532 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 87 $6K
83880 <1% 134 $6K
84702 <1% 476 $6K
80197 <1% 2,502 $6K
85007 <1% 1,244 $6K
84703 <1% 484 $5K
82550 <1% 725 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 160 $5K
82565 <1% 767 $5K
86832 <1% 172 $4K
80051 <1% 587 $4K
83002 <1% 152 $4K
87799 <1% 1,096 $4K
86833 <1% 172 $4K
83001 <1% 139 $4K
76937 <1% 73 $3K
87497 <1% 758 $3K
92579 <1% 59 $3K
82657 <1% 71 $3K
J3535 Drug administered through a metered dose inhaler <1% 67 $3K
84403 <1% 71 $3K
82043 <1% 378 $3K
84425 <1% 90 $3K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 205 $3K
85652 <1% 802 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 39 $2K
86592 <1% 466 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 12 $2K
0352U <1% 81 $2K
84305 <1% 117 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 339 $2K
82670 <1% 53 $2K
82088 <1% 35 $2K
82746 <1% 84 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 34 $2K
88342 <1% 13 $2K
J2704 Injection, propofol, 10 mg <1% 181 $2K
87205 <1% 277 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 56 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 54 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 410 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 26 $1K
84550 <1% 872 $1K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 42 $1K
82040 <1% 169 $1K
82157 <1% 26 $1K
82105 <1% 66 $1K
87210 <1% 233 $1K
96417 <1% 17 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 31 $1K
82677 <1% 42 $1K
A4217 Sterile water/saline, 500 ml <1% 241 $1K
82627 <1% 28 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 13 $1K
83655 <1% 68 $1K
84244 <1% 32 $876.80
97161 <1% 12 $876.03
J1170 Injection, hydromorphone, up to 4 mg <1% 32 $872.23
64642 <1% 14 $858.70
64644 <1% 16 $850.80
86336 <1% 42 $838.00
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 15 $746.29
85018 <1% 260 $731.32
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 202 $699.10
85014 <1% 261 $693.38
86769 <1% 42 $678.37
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 16 $653.28
82340 <1% 84 $538.67
87496 <1% 174 $530.04
J0690 Injection, cefazolin sodium, 500 mg <1% 116 $481.07
Q3014 Telehealth originating site facility fee <1% 100 $468.80
80177 <1% 30 $457.38
83520 <1% 27 $446.85
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 12 $426.10
76377 <1% 64 $385.65
84153 <1% 26 $335.50
J7120 Ringers lactate infusion, up to 1000 cc <1% 44 $308.56
G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) <1% 73 $292.66
84075 <1% 196 $284.37
82310 <1% 158 $271.30
84481 <1% 12 $262.39
87040 <1% 13 $249.38
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 52 $236.28
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 75 $233.63
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 13 $191.52
80500 <1% 13 $178.80
83605 <1% 13 $178.24
87522 Neg quan hep c or qual rna <1% 18 $170.44
82378 <1% 17 $165.48
84165 <1% 27 $163.00
85730 <1% 42 $142.12
84520 <1% 771 $126.90
82947 <1% 606 $115.38
84155 <1% 187 $108.07
J3010 Injection, fentanyl citrate, 0.1 mg <1% 25 $100.96
87186 <1% 13 $97.57
82248 <1% 13 $96.73
85610 <1% 61 $94.46
83521 <1% 27 $82.82
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 766 $56.55
84436 <1% 41 $49.96
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 13 $43.42
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 15 $22.25
C1769 Guide wire <1% 13 $15.77
84132 <1% 13 $5.72
0100U 0% 49 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZUKOWSKI, ANDREW (CFO)
Same official

Other billing entities under ZUKOWSKI, ANDREW

Full network →
ProviderLocationPaid
Pitt County Memorial Hospital INCGreenville, NC$15.64M
Pitt County Memorial Hospital INCWashington, NC$2.97M
Vidant Medical Group Affiliates LLCGreenville, NC$21K
Pitt County Memorial Hospital INCGreenville, NC$30.02

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.